13F HOLDINGS REPORT
ACUTA CAPITAL PARTNERS, LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001104659-24-061603
Total Value
$153.9M
Positions
33
Other Managers
0
Confidential Omitted
No
Holdings (33)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | OCULAR THERAPEUTIX INC | OCUL | 2,635,287 | $24.0M | 15.58% |
| 2 | PRAXIS PRECISION MEDICINES I | PRAX | 162,302 | $9.9M | 6.43% |
| 3 | MERSANA THERAPEUTICS INC | 59045L106 | 2,164,628 | $9.7M | 6.30% |
| 4 | TAYSHA GENE THERAPIES INC | TSHA | 3,333,333 | $9.6M | 6.21% |
| 5 | ROCKET PHARMACEUTICALS INC | RCKTW | 326,787 | $8.8M | 5.72% |
| 6 | SAREPTA THERAPEUTICS INC | SRPT | 64,162 | $8.3M | 5.40% |
| 7 | VAXCYTE INC | PCVX | 104,830 | $7.2M | 4.65% |
| 8 | ENLIVEN THERAPEUTICS INC | ELVN | 396,099 | $7.0M | 4.53% |
| 9 | TOURMALINE BIO INC | 89157D105 | 261,108 | $6.0M | 3.88% |
| 10 | APPLIED THERAPEUTICS INC | 03828A101 | 792,000 | $5.4M | 3.50% |
| 11 | DYNE THERAPEUTICS INC | DYN | 184,500 | $5.2M | 3.40% |
| 12 | DISC MEDICINE INC | IRON | 76,800 | $4.8M | 3.11% |
| 13 | REVOLUTION MEDICINES INC | RVMDW | 143,777 | $4.6M | 3.01% |
| 14 | CELLDEX THERAPEUTICS INC | CLDX | 109,000 | $4.6M | 2.97% |
| 15 | AADI BIOSCIENCES INC | WHWK | 1,849,402 | $4.3M | 2.81% |
| 16 | HILLEVAX INC | 43157M102 | 250,609 | $4.2M | 2.71% |
| 17 | CRINETICS PHARMACEUTICALS | CRNX | 78,403 | $3.7M | 2.38% |
| 18 | VIRIDIAN THERAPEUTICS INC | VRDN | 199,433 | $3.5M | 2.27% |
| 19 | TERNS PHARMACEUTICALS INC | TERN | 465,079 | $3.1M | 1.98% |
| 20 | IMMUNOVANT INC | IMVT | 92,346 | $3.0M | 1.94% |
| 21 | VERASTEM INC | VSTM | 207,095 | $2.4M | 1.59% |
| 22 | ARCELLX INC | ACLX | 34,500 | $2.4M | 1.56% |
| 23 | KURA ONCOLOGY INC. | KURA | 90,000 | $1.9M | 1.25% |
| 24 | INSMED INC | INSM | 61,718 | $1.7M | 1.09% |
| 25 | AGIOS PHARMA | AGIO | 55,262 | $1.6M | 1.05% |
| 26 | ORIC PHARMACEUTICALS INC | ORIC | 103,992 | $1.4M | 0.93% |
| 27 | MEREO BIOPHARMA GROUP PLC | MREO | 397,884 | $1.3M | 0.85% |
| 28 | LYRA THERAPEUTICS INC | LYRA | 173,320 | $1.1M | 0.70% |
| 29 | LEAP THERAPEUTICS INC | CYPH | 354,166 | $942,082 | 0.61% |
| 30 | ULTRAGENYX PHARMACEUTICAL INC | RARE | 20,000 | $933,800 | 0.61% |
| 31 | INTRA-CELLULAR THERAPIES INC. | 46116X101 | 13,300 | $920,360 | 0.60% |
| 32 | CELLECTAR BIOSCIENCES INC. | CLRB | 143,500 | $571,130 | 0.37% |
| 33 | NUVATION BIO | NUVB | 90,832 | $27,477 | 0.02% |